As a senior consultant, Mike Ingram supports the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) at Fort Detrick. Mike joined LMI in November 2020 after 24 years in the U.S. Army, serving most of his military career as a microbiology officer in the Army Medical Department. In that role, he led the military’s efforts to develop COVID-19 non-human primate animal models for vaccine and drug development.
What are you responsible for as Senior Consultant, Biology at LMI?
I review COVID-19 diagnostic proposals and present the assessment outcomes to government clients for their use and implementation.
How long have you been with LMI?
I joined LMI in November 2020.
How long were you in the United States Army?
I served in the U.S. Army for a total of 24 years. For three of those years I was enlisted infantry and spent 21 years as a microbiology officer in the Army Medical Department.
What was your role in the U.S. Army?
I was a 71A, an Army Microbiologist. I served in [Science and Technology] Management in research and operationally in field laboratories for chemical/biological threat agents. I also spent much of my career in project management for the development of advanced medical countermeasures, including drugs and diagnostics.
Of your many accomplishments while serving as a leader in the United States Army, what makes you the proudest?
One of my greatest successes was leading the development of the first FDA-accepted pre-Emergency Use Authorization (EUA) diagnostic assays for filovirus species (Ebola and Marburg). Two years after the FDA accepted all the data and forms for the pre-EUA, the largest Ebola outbreak occurred in western Africa. Our pre-EUA was authorized and became the gold standard diagnostic for any American coming back into the U.S.
"My military experience in medical product development for chemical/biological defense and Army medical countermeasures is invaluable for my clients, as is my scientific and regulatory expertise."